Researcher
Carl June
Immunology University of Pennsylvania
Profile
Carl June is a pioneer of CAR-T cell therapy who developed the first FDA-approved gene therapy, Kymriah, for cancer treatment. His work in engineering patients' own immune cells to attack tumors has transformed cancer immunotherapy.
179 H-Index
1420 Publications
40 Grants
38 Patents
Industry Ties
Novartis Tmunity Therapeutics Capstan Therapeutics
Verified employment, education, publications and profile data sourced from ORCID. Locked — unlock to view.
Employment
Unlock to view
Education
Unlock to view
Works
Unlock to view
Biography
Unlock to view
Keywords
Unlock to view
Links
Unlock to view
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →